Howard Hughes Medical Institute’s PureCycle Technologies PCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-741,891
Closed -$4.61M 2
2024
Q1
$4.61M Hold
741,891
1.39% 2
2023
Q4
$3M Hold
741,891
1% 2
2023
Q3
$4.16M Sell
741,891
-886,679
-54% -$8.31M 21.25% 2
2023
Q2
$17.4M Hold
1,628,570
24.72% 2
2023
Q1
$11.4M Hold
1,628,570
20.23% 2
2022
Q4
$11M Hold
1,628,570
6.13% 4
2022
Q3
$13.1M Hold
1,628,570
3.74% 7
2022
Q2
$12.1M Hold
1,628,570
6.53% 3
2022
Q1
$13M Buy
1,628,570
+428,570
+36% +$3.13M 5.71% 5
2021
Q4
$11.5M Hold
1,200,000
4.5% 7
2021
Q3
$15.9M Hold
1,200,000
5.37% 3
2021
Q2
$28.4M Sell
1,200,000
-465,694
-28% -$10M 9.49% 3
2021
Q1
$42.5M Buy
+1,665,694
New +$48.8M 14.46% 2

Other funds holding PCT

Howard Hughes Medical Institute's PCT Position: Q2 2024 in Review

Howard Hughes Medical Institute sold out of PureCycle Technologies (PCT) in Q2 2024, closing a stake of 741,891 shares — an estimated $4.61M sold.

Howard Hughes Medical Institute first reported a position in PCT in Q1 2021 and held it in 13 quarters. The position peaked at $42.5M in Q1 2021. 186 funds tracked by Wall St. Rank hold PCT as of Q2 2024.

  • Howard Hughes Medical Institute reported no remaining PureCycle Technologies position as of Q2 2024 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 741,891 PureCycle Technologies shares in Q2 2024, an estimated $4.61M.
  • Howard Hughes Medical Institute first reported a position in PureCycle Technologies in Q1 2021 and held it in 13 quarters.
  • Howard Hughes Medical Institute's PureCycle Technologies position peaked at $42.5M in Q1 2021.
  • 186 funds tracked by Wall St. Rank held PureCycle Technologies as of Q2 2024.

Based on Howard Hughes Medical Institute's 13F filing for Q2 2024, filed 14 Aug 2024.